Navigation Links
FDA to Revise Herpes Test Rules in the US

The Food and Drug Administration (FDA) of the United States proposes to revise rules that could make herpes virus tests cheaper and more extensively available.//

The FDA said it might change the classification of tests for herpes simplex virus types 1 and 2 to class II from class III, which would reduce the regulatory burdens associated with the tests.

The change would pave the way for companies seeking to develop and market herpes tests, and also relax the training requirements for laboratories and medical offices that offer the tests, an FDA spokesperson said.

The FDA had considered reclassifying the tests as long ago as 1980, but had said the tests posed a "potential unreasonable risk of illness or injury" at the time. With the older tests, a false positive could expose a pregnant mother or her baby to unnecessary treatment with antiviral drugs or lead to an unnecessary Caesarean delivery of the child. A false negative could result in the infection of a newborn infant, which could be fatal.

The FDA says the reliability and performance of the tests has improved now. It has set a deadline of April 10 for comments on the reclassification.

At least 45 million Americans 12 and older have genital herpes, which is generally caused by the type 2 virus, according to the Centers for Disease Control and Prevention.


'"/>




Page: 1

Related medicine news :

1. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
2. Revised Pregnancy Counselling Item Still Flawed
3. Royal College Issues Revised Guidelines for Face Transplantation
4. Government Allot More Funds for Revised TB Program
5. Revised Cholesterol Guidelines Causes Concern Among Medical Community
6. Drug Stops Herpes
7. Drug Found To Reduce The Transmission Of Herpes
8. Cancer Causing Herpes Virus At Last May Have A Cure
9. Treating Latent Herpes With Licorice
10. Experts Insist That Neonatal Herpes Be Reported Regularly
11. Protection against HIV and Herpes is possible with the Experimental Microbicide
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... support, and collaboration, announces Mirroring360 Pro . This new addition to the ... collaboration experience for education and business. , Mirroring360 Pro enables educators, business professionals ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... and HR decision-makers are preparing for how his administration could impact the employee ... insight into what changes are most likely to make it through Congress. His ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace – from ... be heartened by the industry’s current surge. But another thing that unifies them is ... At last they can simply, safely and effectively end their aroma anguish thanks to ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South Florida ... report in the May issue of Consumer Reports focused on heart health. , ... achieved during and after coronary bypass and aortic valve replacement procedures. , Consumer ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
(Date:4/18/2017)... 18, 2017  Astute Medical, Inc., developer of biomarkers ... be presented at the 2017 National Kidney Foundation (NKF) ... continues through April 22. Physicians will present data on ... assess risk for acute kidney injury (AKI) during the ... Elevated levels of TIMP-2 and IGFBP-7 ...
Breaking Medicine Technology: